9/20
Medicine
Deans of health schools discuss climate change in their fields
Deans and leaders from the schools of Medicine, Veterinary Medicine, Dental Medicine, Nursing, and Social Policy & Practice discussed climate and health at a Climate Week event.
Can the COVID playbook help end malaria?
In a Perry World House conversation, Matthew Laurens, Martina Mchenga, and Drew Weissman discussed how lessons from a global pandemic could help in the fight to eradicate malaria.
The new U.S. plan to target xylazine-laced fentanyl
Researchers from Penn LDI, in conjunction with the Center for Health Economics of Treatment Interventions for Substance Use Disorder, analyze the plan and raise the question of whether it goes far enough.
A link between memory and appetite in the brain to explain obesity
Penn Medicine researchers have found the hippocampal subnetwork, located within the memory center of the brain, is more dysregulated in patients with higher body mass indexes, leading to an inability to control or regulate eating habits.
Eidos LGBTQ+ Health Initiative connects community
Based in Penn’s School of Nursing, the Eidos Initiative provides innovators in LGBTQ+ health with access to resources, research, and support from all of Penn’s 12 schools.
To increase acceptance of an RSV vaccine, explain the FDA’s vaccine approval process
A new report by Penn’s Annenberg Public Policy Center shows a need for more public visibility of the FDA’s rigorous review process to sway public opinion about the safety of vaccines and maternal health during pregnancy.
How machine learning could aid compatibility in kidney transplantation
Through the PURM internship program, undergraduate students are further researching an algorithm developed to group kidney donor-recipient pairs into low-risk and high-risk groups for graft survival.
To reduce medical errors, connect doctors with other doctors
A new study from Annenberg’s Damon Centola uncovers how information-sharing networks can improve medical care.
‘In vivo’ RNA-based gene editing model for blood disorders developed
Researchers from Penn Medicine and The Children’s Hospital of Philadelphia show that gene editing tools can be delivered via lipid nanoparticles, which would reduce cost and increase access to cutting-edge gene therapies.
Could psychedelics simultaneously treat chronic pain and depression?
This summer, Ahmad Hammo, a rising third-year student in the School of Engineering and Applied Science, is conducting a pilot study to explore psilocybin’s potential as a therapy for chronic pain and the depression that often accompanies it.
Media Contact
In the News
My brother’s recovery from a car crash became a lesson in how to talk to doctors and nurses
Emily Largent of the Perelman School of Medicine writes that communication is part of healing, as she experienced when her brother was in a car accident and unable to notify family himself.
FULL STORY →
In-hospital strokes like Charlie Manuel’s are common
Steven Messé of the Perelman School of Medicine has been working on a solution to a long-standing problem in stroke care and says that for a variety of reasons in-hospital strokes sometimes are not detected until hours after they occur.
FULL STORY →
Penn researcher’s Every Cure nonprofit lands ‘game-changing’ support as it works to help patients with uncurable diseases
David Fajgenbaum of the Perelman School of Medicine comments on “game-changer” funding for the nonprofit Every Cure, which he co-founded.
FULL STORY →
Penn biomedical scientists move into new uCity complex with 115,000 square feet of lab space
More than 50 Penn scientists and staff, including the Perelman School of Medicine’s Drew Weissman, are moving into 115,000 square feet of new lab space in the 13-story One uCity Square building.
FULL STORY →
The White House proposed staffing requirements for nursing home. What would that mean for Pennsylvania?
Rachel Werner of the Leonard Davis Institute, the Perelman School of Medicine, and the Wharton School explains why an increase in nursing home staffing levels is sorely needed.
FULL STORY →
Silicon Valley’s quest to live forever now includes $2,500 full-body MRIs
Saurabh Jha of the Perelman School of Medicine says that the only way to know if incidental MRI findings are benign is to keep getting scanned, which is costly to the individual and to the health system.
FULL STORY →